Overview
A three-month ESO observership on managing oligoprogressive cancer with stereotactic radiotherapy integrated with immunotherapy and targeted therapies.
The programme
- Focus
- Stereotactic radiotherapy (SBRT/SRS)
- Training type
- Visiting Observership (ESO Clinical Training Centre)
- Duration
- 3 months
- Start
- Not stated on official page
- Positions
- Not stated on official page
- Accreditation
- European School of Oncology (ESO) Clinical Training Centres Fellowship Programme
- Department
- Not stated on official page
Eligibility and visa
- Eligibility
- Young and promising oncology professionals (radiation oncologists / pathologists in training or early career)
- International applicants
- Yes — open to young oncology professionals; 2026 ESO CTC fellows came from Egypt, Peru, Kazakhstan, Georgia, Kosovo, Serbia and elsewhere
- Visa support
- Not stated on official page
- Licence requirement
- Observership; English language
How to apply
- Deadline
- Not stated on official page
- Application method
- Apply to the ESO CTC Fellowship Programme (priority selection for ESO College students, fellows and graduates); enrolment procedure discussed with the host institute
Funding
- Funding
- Not stated on official page
Official sources
https://www.eso.net/ctc-program/approach-to-patients-with-oligoprogression-using-stereotactic-radiotherapy/https://www.eso.net/education-and-training/clinical-training-centres-fellowship-programme/https://www.eso.net/education-and-training/clinical-training-centres-fellowship-programme/annual-fellows-nomination/